BamSEC and AlphaSense Join Forces
Learn More

Pluri Inc.

NASDAQ: PLUR    
Share price (12/20/24): $4.82    
Market cap (12/20/24): $26.8 million

Indentures Filter

EX-4.1
from 10-K 2 pages Description of Securities
12/34/56
EX-4.1
from 8-K 12 pages Common Stock Purchase Warrant Pluri Inc
12/34/56
EX-4.3
from 10-K 1 page Description of Securities
12/34/56
EX-4.2
from S-3 3 pages Pluristem Therapeutics Inc. Amended and Restated Articles of Incorporation as Amended as of July 25, 2019 July 2, 2020 First
12/34/56
EX-4.1
from S-3 3 pages Pluristem Therapeutics Inc. Amended and Restated Articles of Incorporation as Amended as of July 2, 2020 First
12/34/56
EX-4.3
from 10-K 1 page Description of Securities
12/34/56
EX-4.1
from 10-Q 29 pages Pluristem Therapeutics Inc. and American Stock Transfer & Trust Company, LLC, as Warrant Agent Warrant Agent Agreement Dated as of April 4, 2019 Warrant Agent Agreement
12/34/56
EX-4.1
from 8-K 29 pages Pluristem Therapeutics Inc. and American Stock Transfer & Trust Company, LLC, as Warrant Agent Warrant Agent Agreement Dated as of April 4, 2019 Warrant Agent Agreement
12/34/56
EX-4.1
from 8-K 17 pages Common Stock Purchase Warrant Pluristem Therapeutics Inc
12/34/56
EX-4.1
from 8-K 16 pages Common Stock Purchase Warrant Pluristem Therapeutics, Inc
12/34/56
EX-4.1
from S-8 3 pages Pluristem Therapeutics Inc. Amended and Restated Articles of Incorporation as Amended as of May 22, 2014 First
12/34/56
EX-4.1
from 10-Q 21 pages Warrant Agreement
12/34/56
EX-4.1
from 8-K 21 pages Warrant Agreement
12/34/56
EX-4.1
from 8-K 21 pages Warrant Agreement
12/34/56
EX-4.2
from 10-Q 17 pages Warrant Agreement
12/34/56
EX-4.1
from 8-K 21 pages Warrant Agreement
12/34/56
EX-4.1
from 8-K 11 pages Pluristem Therapeutics Inc. Common Stock Purchase Warrant
12/34/56
EX-4.1
from 8-K 11 pages Pluristem Therapeutics Inc. Common Stock Purchase Warrant
12/34/56
EX-4.1
from 8-K ~10 pages Common Stock Purchase Warrant Pluristem Therapeutics Inc
12/34/56
EX-4.1
from 8-K ~10 pages Common Stock Purchase Warrant Pluristem Therapeutics Inc
12/34/56